The Efficacy and Safety of Off-Label Dupilumab in Acantholytic Dyskeratotic Disorders: A Brief Report

Published: 10 September 2025| Version 1 | DOI: 10.17632/c6nb55pjsx.1
Contributors:
,
,
,

Description

Supplementary Table S1: Search strategy across databases searched Supplementary Table S2: Summary of included literature

Files

Steps to reproduce

For any reproduction requested, please contact corresponding author: Dr. Touraj Khosravi-Hafshejani, MD Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, BC, Canada 835 West 10th Avenue, Vancouver, BC, Canada Email: Touraj_k@alumni.ubc.ca

Institutions

  • The University of British Columbia Department of Dermatology & Skin Science
  • McGill University Faculty of Medicine
  • Universite de Montreal
  • The University of British Columbia Faculty of Medicine

Categories

Medicine, Dermatology, Dermatological Disease, Therapeutics

Licence